Short sellers are retreating from CI. Short interest has dropped 33% over the past month. That's the dominant story in this convergence — but it's playing out against a backdrop of analyst downgrades and elevated options hedging.
Short interest in The Cigna Group hit 1.85% of free float on August 11. A month ago, it stood at 2.75%. The pace of retreat is striking: shorts fell 11% in a single week and 33% over the past month.
At these levels, SI is low in absolute terms. But the speed of covering is the signal worth watching. Short sellers aren't just trimming — they're unwinding positions at an accelerating clip.
While shorts exit, options traders are hedging. The put-call ratio spiked to 0.586 on August 10 — nearly 2.1 standard deviations above its 20-day mean of 0.471. It has since pulled back to 0.549. Still, the PCR remains elevated relative to the prior two months, when readings mostly clustered around 0.41–0.43.
That divergence is notable. Short sellers cover. Options buyers hedge. Both moves can coexist — covering shorts reduces downside risk, while put demand reflects residual caution about what comes next.
Two downgrades landed in rapid succession in early August. Jefferies cut CI to Hold from Buy, lowering its target to $307. Raymond James stepped down to Outperform from Strong Buy, with a target of $320. Both firms acted within 24 hours of each other on August 3–4.
The stock trades at $273.87, roughly 7–10% below those revised targets. Consensus remains a buy — 13 analysts bullish versus 5 at hold — but the direction of travel has shifted.
CI fell 5.9% on July 30 earnings. It has lost 6.7% over the past month. The next earnings date is October 30.
Cost to borrow spiked mid-week to 0.50%, triggering the CTB pulse. It has since retreated to 0.30%. Availability remains enormous — the borrow pool is effectively unconstrained. This is not a short-squeeze setup.
See the live data behind this article on ORTEX.
Open CI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
